Disease Knowledge Limited Among Individuals With Type 2 Diabetes
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 13, 2024 -- There is considerable room for improvement of disease knowledge among individuals with type 2 diabetes (T2D), according to a study published online March 7 in Frontiers in Public Health.
Pedro L. Ferreira, Ph.D., from the Centre for Health Studies and Research of the University of Coimbra in Portugal, and colleagues examined the diabetes knowledge of a T2D population in a cross-sectional, observational study in a convenience sample. Individuals diagnosed with T2D attending ambulatory visits from five health settings, older than 18 years, with a time diagnosis of at least one year, and attending multidisciplinary visits for at least three months were identified. The Portuguese version of the Diabetes Knowledge Test was applied to assess knowledge in 1,200 individuals, ranging in age from 24 to 94 years (mean age, 65.6 ± 11.4 years); 39.9 percent were insulin-treated.
The researchers found that the percentage of correct answers was 51.8 and 58.7 percent for non-insulin- and insulin-treated individuals, respectively. Three items had a percentage of correct answers lower than 15 percent: 4.4, 11.9, and 13.3 percent related to the identification of signs of ketoacidosis, identification of which food should not be used to treat low blood glucose, and regarding knowledge of free food, respectively.
"The results of this study reinforce the need to improve the disease knowledge of T2D patients and to enable them to achieve better health outcomes," the authors write. "Some of the factors associated with the limited diabetes knowledge are modifiable, and can be addressed through more targeted interventions."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.